Submandibular Gland Neoplasms
Showing 1 - 25 of 3,310
Head Neck Cancer Trial in Groningen (Submandibular Gland Stem Cell Transplantation)
Recruiting
- Head and Neck Cancer
- Submandibular Gland Stem Cell Transplantation
-
Groningen, NetherlandsUMCG
May 24, 2022
Head and Neck Tumors, Swallowing Sparing IMRT Trial in Jhajjar (Swallowing and submandibular sparing IMRT)
Recruiting
- Head and Neck Neoplasms
- Swallowing Sparing IMRT
- Swallowing and submandibular sparing IMRT
-
Jhajjar, Haryana, IndiaNci, Aiims
Jan 17, 2022
Neck Dislocation, Oral Cancer Trial in Beijing (modified neck dissection, traditional neck dissection)
Recruiting
- Neck Dislocation
- Oral Cancer
- modified neck dissection
- traditional neck dissection
-
Beijing, Beijing, ChinaPeking University School of Stomatology
Sep 23, 2021
Head Neck Cancer Trial in Columbus (drug, radiation, procedure)
Terminated
- Head and Neck Cancer
- Cisplatin
- +3 more
-
Columbus, OhioOhio State University Medical Center
Oct 29, 2021
Submandibular Gland Tumor, Parotid Gland Tumor Trial in Stanford (Alda-341)
Completed
- Submandibular Gland Tumor
- Parotid Gland Tumor
-
Stanford, CaliforniaStanford University
Mar 3, 2020
Sialendoscopy in Treatment of Submandibular Gland Sialolithiasis
Active, not recruiting
- Lithiasis
-
Metz, Moselle, FranceCHR Metz Thionville
Jul 29, 2021
Pattern and Surgical Treatment of Parotid Gland Neoplasms
Recruiting
- Parotid Gland Neoplasm
-
Sohag, EgyptFaculty of Medicine Sohag University
Aug 16, 2022
Endocrine Neoplasms
Recruiting
- Endocrine Tumors
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
GENE EXPRESSION PROFILING IN A VALIDATION COHORT OF LOCALLY
Not yet recruiting
- Salivary Gland Cancer
- Observation
- (no location specified)
Oct 13, 2023
Immune Biomarker Study for Salivary Gland Carcinoma
Not yet recruiting
- Salivary Gland Tumor
- Benign Salivary Gland Tumor
- Sampling
-
Erlangen, Bavaria, Germany
- +1 more
Sep 21, 2023
Gland, Salivary Gland Cancers Trial in Houston (Sacituzumab Govitecan)
Not yet recruiting
- Gland
- Salivary Gland Cancers
- Sacituzumab Govitecan
-
Houston, TexasM D Anderson Cancer Center
May 22, 2023
Advanced Salivary Gland Carcinoma Trial in Shanghai (SHR-A1811, SHR 3680 + leuprolide, SHR-A1921)
Not yet recruiting
- Advanced Salivary Gland Carcinoma
- SHR-A1811
- +2 more
-
Shanghai, ChinaDongmei Ji
Jun 21, 2023
Salivary Gland Tumor, Diagnosis Trial in Thessaloníki (Fine Needle Aspiration, Histologic Examination)
Completed
- Salivary Gland Tumor
- Diagnosis
- Fine Needle Aspiration
- Histologic Examination
-
Thessaloníki, GreeceAristotle University
Sep 11, 2023
PSMA-PET Imaging of Salivary Gland Tumours and Other Rare
Recruiting
- Salivary Gland Tumor
- Rare Malignant Neoplasm
- 68-Ga PSMA PET scan
-
Singapore, SingaporeNational Cancer Centre Singapore
Oct 11, 2022
Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination
Not yet recruiting
- Salivary Gland Cancer
- vedicitumomab (Edisil, RC48)
- +3 more
- (no location specified)
Jun 9, 2023
TEXTBOOK OUTCOME IN ADRENAL NEOPLASMS
Completed
- Outcome Assessment
- Adrenal Neoplasm
- Adrenalectomy
-
Alicante, SpainJuan Jesús Rubio García
May 24, 2023
Study of Adrenal Gland Tumors
Completed
- Adrenal Gland Neoplasm
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)
Recruiting
- Salivary Gland Cancer
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Oct 27, 2022
Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in
Recruiting
- Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
- +2 more
- Vedolizumab
- +5 more
-
Beijing, Beijing, China
- +1 more
Nov 21, 2023
Salivary Gland Cancer, HER2 Gene Mutation Trial in Boston (Ado-trastuzumab (T) emtansine (T-DM1), Standard of Care Radiotherapy,
Recruiting
- Salivary Gland Cancer
- HER2 Gene Mutation
- Ado-trastuzumab (T) emtansine (T-DM1)
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 2, 2023
Salivary Gland Cancer, Salivary Gland Tumors Trial in Novi Sad (Surgical intervention with or without postoperative adjuvant
Completed
- Salivary Gland Cancer
- Salivary Gland Neoplasms
- Surgical intervention with or without postoperative adjuvant therapy
-
Novi Sad, SerbiaClinic for maxillofacial surgery Clinical center of Vojvodina
May 22, 2022
High-grade Salivary Gland Carcinoma Trial in Seoul (nivolumab, docetaxel, cisplatin Group)
Recruiting
- High-grade Salivary Gland Carcinoma
- nivolumab, docetaxel, cisplatin Group
-
Seoul, Korea, Republic ofDepartment of Medicine, Samsung Medical Center, Sungkyunkwan Uni
Feb 3, 2023
Salivary Gland Tumor Trial in Philadelphia (MRI)
Recruiting
- Salivary Gland Tumor
- MRI
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Jun 19, 2022
Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial
Not yet recruiting
- Locally Advanced Salivary Gland Carcinoma
- +3 more
- Biopsy
- +3 more
- (no location specified)
Jan 10, 2023